triazolam has been researched along with Delayed Effects, Prenatal Exposure in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Excerpt | Relevance | Reference |
---|---|---|
"Triazolam, which is a substrate of Cyp3a, was intraperitoneally administered to the mice in the HF group." | 1.38 | Consumption of a high-fat diet during pregnancy decreases the activity of cytochrome P450 3a in the livers of offspring. ( Ikarashi, N; Imahori, Y; Ishii, M; Kon, R; Kusunoki, Y; Ochiai, W; Okaniwa, T; Saruta, K; Sugiyama, K; Tajima, M; Toda, T; Yamada, H, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tajima, M | 1 |
Ikarashi, N | 1 |
Imahori, Y | 1 |
Okaniwa, T | 1 |
Saruta, K | 1 |
Ishii, M | 1 |
Kusunoki, Y | 1 |
Kon, R | 1 |
Toda, T | 1 |
Ochiai, W | 1 |
Yamada, H | 1 |
Sugiyama, K | 1 |
1 other study available for triazolam and Delayed Effects, Prenatal Exposure
Article | Year |
---|---|
Consumption of a high-fat diet during pregnancy decreases the activity of cytochrome P450 3a in the livers of offspring.
Topics: Animals; Animals, Newborn; Area Under Curve; Blood Glucose; Body Weight; Cytochrome P-450 CYP3A; Die | 2012 |